TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Pharmaxim AB
Closing information (x1000 NOK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
200,526
|
176,773
|
145,003 |
| Financial expenses |
1,022
|
927
|
396 |
| Earnings before taxes |
6,535
|
11,811
|
8,824 |
| EBITDA |
7,974
|
13,143
|
9,321 |
| Total assets |
105,777
|
91,980
|
86,670 |
| Current assets |
74,137
|
60,713
|
60,106 |
| Current liabilities |
42,429
|
28,689
|
45,067 |
| Equity capital |
47,332
|
45,458
|
38,906 |
| - share capital |
1,186
|
1,165
|
1,088 |
| Employees (average) |
16
|
14
|
15 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
44.7%
|
49.4%
|
44.9% |
| Turnover per employee |
12,533
|
12,627
|
9,667 |
| Profit as a percentage of turnover |
3.3%
|
6.7%
|
6.1% |
| Return on assets (ROA) |
7.1%
|
13.8%
|
10.6% |
| Current ratio |
174.7%
|
211.6%
|
133.4% |
| Return on equity (ROE) |
13.8%
|
26.0%
|
22.7% |
| Change turnover |
20,565
|
21,481
|
-27,688 |
| Change turnover % |
11%
|
14%
|
-16% |
| Chg. No. of employees |
2
|
-1
|
-1 |
| Chg. No. of employees % |
14%
|
-7%
|
-6% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.